Search clinical trials for: Sacituzumab Govitecan-hiy
Total 5893 results
-
Georgetown UniversityGilead SciencesRecruitingThymic Carcinoma | ThymomaUnited States
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
Gilead SciencesApproved for marketingMetastatic Triple-Negative Breast Carcinoma
-
Gilead SciencesRecruitingLiver Failure | Advanced or Metastatic Solid TumorFrance, United States
-
Fudan UniversityRecruiting
-
The University of Texas Health Science Center at...Recruiting
-
Gilead SciencesRecruiting
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Veru Inc.WithdrawnMetastatic Triple Negative Breast Cancer
-
M.D. Anderson Cancer CenterGilead SciencesRecruitingSalivary Gland Cancers | GlandUnited States
-
Icahn School of Medicine at Mount SinaiNot yet recruitingOvarian Cancer | Malignant Neoplasm of UterusUnited States
-
Gilead SciencesEnrolling by invitationMetastatic Solid TumorFrance, United States, Belgium
-
University Hospital HeidelbergNot yet recruitingMetastatic Colorectal CancerGermany
-
SOLTI Breast Cancer Research GroupNot yet recruitingBreast Cancer Stage IVSpain
-
The University of Texas Health Science Center at...Gilead SciencesActive, not recruiting
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
National Cancer Institute (NCI)RecruitingAdvanced Solid Tumors | SCLC | HRD CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Gilead SciencesRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic HER2 Negative Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteGilead SciencesActive, not recruitingBladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterUnited States
-
IRCCS San RaffaeleHigh ResearchRecruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)SuspendedMetastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast CarcinomaUnited States
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Yale UniversityGilead SciencesRecruitingEndometrial CarcinomaUnited States
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead SciencesActive, not recruiting
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States, Israel
-
Gilead SciencesActive, not recruitingNon-Small Cell Lung CancerUnited States, Belgium, Spain, United Kingdom, Australia, Japan, Italy, France, Israel, Netherlands, Puerto Rico, Portugal, Greece, Brazil, Poland, Canada, Austria, Germany, Mexico, Turkey
-
Gilead SciencesRecruiting
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
University of Kansas Medical CenterGilead Sciences; Novartis PharmaceuticalsRecruitingBreast CancerUnited States
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Massachusetts General HospitalPfizerRecruiting
-
Maastricht University Medical CenterGilead SciencesNot yet recruitingNSCLC Stage IV | Brain Metastases, AdultNetherlands
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Dragonfly TherapeuticsRecruitingSolid Tumor, AdultUnited States, Denmark, Netherlands, Belgium, France
-
Merck Sharp & Dohme LLCGilead SciencesRecruitingCarcinoma, Non-Small-Cell LungChina, Poland, Latvia, United States, Taiwan, Australia, Turkey, Germany, Israel, Korea, Republic of, Estonia, Romania, Chile, Italy, Brazil, Greece, Philippines, Canada, Japan, Malaysia, United Kingdom, Lithuania, Thailand, Peru
-
Gilead SciencesMerck KGaA, Darmstadt, GermanyRecruitingMetastatic Urothelial CancerItaly, United States, Korea, Republic of, Spain, Greece, France, Germany, United Kingdom, Turkey
-
University of WashingtonGilead SciencesRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Chinese University of Hong KongRecruiting
-
M.D. Anderson Cancer CenterGilead SciencesRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
H. Lee Moffitt Cancer Center and Research InstituteGilead SciencesNot yet recruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Grupo Espanol de Tumores NeuroendocrinosGilead Sciences; MFARNot yet recruitingDifferentiated Thyroid Cancer | Anaplastic Thyroid CancerSpain
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Omar MianGilead Sciences; Varian IncRecruitingMuscle-Invasive Bladder Carcinoma | Localized Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Yale UniversityGilead SciencesRecruitingOvarian CarcinomaUnited States